2025 annual financial data
Filana Therapeutics 2025 Operating margin
Filana Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -95,390,000 USD and net income was -90,973,000 USD.
Operating cash flow was -32,252,000 USD.
Get free Filana Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -95,390,000 USD
- Net income
- -90,973,000 USD
- Operating cash flow
- -32,252,000 USD